Latest Manufacturing News

AML3D has secured a AU$1.2 million order from Austal USA for a portable ARCEMY Small additive manufacturing system, set to enhance the US Navy’s manufacturing capabilities with rapid deployment and flexible use.

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

Elsight Limited reports unprecedented revenue growth in Q2 and H1 2025, driven by major defence contracts and expanding market demand. The company is on track to achieve profitability in the second half of the year.

AnteoTech has signed a binding Term Sheet with US-based Black Diamond Structures to jointly develop and commercialise an advanced battery additive combining their proprietary technologies, targeting improved lithium-ion battery anodes with higher silicon content.

Amaero Ltd reports solid June quarter revenue and signs a pivotal five-year exclusive supply agreement with Velo3D, underpinning its growth outlook and updated EBITDA guidance for FY2027.

Tivan Limited and Sumitomo Corporation have signed a Memorandum of Understanding to jointly develop the high-grade Sandover Fluorite Project in Australia's Northern Territory, marking a significant step in Australia's critical minerals sector.

Cleo Diagnostics reports steady progress in its ovarian cancer diagnostic test development, with clinical trial recruitment on track and strategic access to major biobanks enhancing its regulatory pathway.

Tivan and Sumitomo Corporation have formalised their joint venture for the Speewah Fluorite Project, securing a strategic investment from Japan’s JOGMEC. This partnership marks a significant step towards advancing the project’s feasibility and strengthening Australia-Japan critical minerals ties.

Meteoric Resources has released a robust Pre-Feasibility Study for its Caldeira rare earths project in Brazil, highlighting a low-cost, long-life deposit with strong government backing and a targeted production start in 2028.

Tryptamine Therapeutics has begun recruiting patients for a pioneering clinical trial testing IV-infused psilocin combined with psychotherapy to treat Binge Eating Disorder, aiming to deliver faster and more controlled treatment outcomes.

Firebird Metals has secured two key patents for its proprietary Lithium Manganese Iron Phosphate (LMFP) battery materials, reinforcing its position in the emerging $20 billion LMFP market. The company’s integrated production approach and expanding IP portfolio set the stage for global growth amid shifting technology controls.

Connexion Mobility reported steady revenue growth and a 7% increase in net profit before tax for Q4 FY25, driven by expanding SaaS subscriptions and strategic product enhancements.